Report Overview:
The following report titled “Global Cell Gene Therapy Drug Delivery Devices Market: By Product Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe (Size 1.0 ML, 31-Gauge Needle), (Size 0.5 ML, 22-Gauge Needle)), Pre-Filled Syringe (Size 1.0 ML, 22-26 Gauge Needle), (Size 4.0 ML, 22-26 Gauge Needle)), Infusion Bags (Size 10 ML to 50 ML), (Size 68 ML), (Size 60 ML), (Size Up to 65 ML)), By Technology (Microchip Technology, Nano-Technology, Lipid Nanoparticles) and other forecast 2023-2028” provides a comprehensive analysis of the market, focusing on key details such as market size, growth trends, determinants of growth, segments covered, and the role of leading players in the industry.
Global Cell Gene Therapy Drug Delivery Devices Market Summary
The Global Cell Gene Therapy Drug Delivery Devices Market is anticipated to grow at a CAGR of around 14% during the forecast period, i.e., 2023-28, says MarkNtel Advisors. The market is driven primarily by massive funding by numerous leading players in the technological advancements to bring cost-effective therapies devices, coupled with the increasing number of FDA approvals for cell gene therapies clinical trials.
Report Coverage Details
- Forecast Period: 2023-2028
- Base Year: 2022
- CAGR: 14%
“In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”
Download Free PDF Brochure: - https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html
Cell Gene Therapy Drug Delivery Devices Market Driver:
The factors that are projected to drive the market in the coming years include the following:
- Substantial investments in RD, particularly across the US, for the development of new improved cell gene therapies
- Mounting prevalence of genetic disorders chronic diseases
- An increasing number of FDA approvals for cell gene therapies their clinical trials.
Segmentation Analysis: Cell Gene Therapy Drug Delivery Devices Market
By Product Type
- Sub-retinal Injection Cannula
- Extension Tube
- Intravenous Catheter
- Sterile Insulin Syringe
- Size 1.0 ML, 31-Gauge Needle
- Size 0.5 ML, 22-Gauge Needle
- Pre-Filled Syringe
- Size 1.0 ML, 22-26 Gauge Needle
- Size 4.0 ML, 22-26 Gauge Needle
- Infusion Bags
- Infusion Bags (Size 10 ML to 50 ML)
- Infusion Bags (Size 68 ML)
- Infusion Bags (Size 60 ML)
- Infusion Bags (Size Up to 65 ML)
By Technology
- Microchip Technology
- Nano-Technology
- Lipid Nanoparticles
By Commercialized Drugs
- Luxturna
- Kymriah
- Yescarta
- Zolgensma
- Provenge
- Strimvelis
By End-User
- Pharmaceuticals Biotechnology Company
- Academic Research Institute
- Hospitals Clinics
By Region
- North America
- South America
- Europe
- Middle East Africa
- Asia-Pacific
Access Full Report [Include Description + TOC] - https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html
Region: North America Holds a Major Market Share
Of all the regions, North America attained more than 50% of the revenue share and is anticipated to prevail the same trend in the forecast period.
Leading Players Analysis: Cell Gene Therapy Drug Delivery Devices Market
The report provides detailed analysis of key players in the global Cell Gene Therapy Drug Delivery Devices market, highlighting their strategies and competitive scenario.
- Amgen Inc.
- Bausch Lomb Incorporated
- Becton, Dickinson and Company
- Bluebird bio Inc.
- Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
- Dendreon Pharmaceuticals LLC
- Helixmith Co. Ltd (ViroMed Co., Ltd)
- Human Stem Cells Institute
- Kite Pharma Inc.
- Kolon TissueGene, Inc.
- Novartis AG
- Orchard Therapeutics plc.
- Pfizer Inc.
- Renova Therapeutics
- Spark Therapeutics Inc.
- uniQure N.V.
- Vericel Corporation
Note: Should you require specific information beyond the current scope of the report, we are prepared to furnish it as part of our customization services.
For Customized Report Inquiry: - https://www.marknteladvisors.com/query/request-customization/cell-gene-therapy-drug-delivery-devices-market.html
Key Benefits for Stakeholders:
- Informed Decision-Making: Access to comprehensive and insightful market research reports enables stakeholders to make well-informed decisions, leading to more strategic and successful initiatives.
- Strategic Planning: The strategic reports provided by MarkNtel Advisors empower stakeholders to formulate robust strategies for market entry, product development, and competitive positioning.
- Market Sizing Forecasting: Stakeholders can benefit from accurate market sizing and forecasting data to make informed investment and resource allocation decisions, minimizing risks and maximizing returns.
- Competitive Benchmarking: The availability of competitive benchmarking data allows stakeholders to assess their performance against industry peers, identify areas for improvement, and capitalize on strengths.
- Identifying Investment Opportunities: Through trend analysis and industry insights, stakeholders can identify attractive investment opportunities and stay ahead in the market for better ROI.
About us
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative quantitative research company, strive to deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East Africa, etc., and many countries across the regional scale, namely, the US, Saudi Arabia, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Information:
- Address: Office No.106, H-160, Sector 63, Noida, Uttar Pradesh - 201301, India
- Call (India): +91 120 4278433
- Call (USA): +1 628 895 8081
- Email: sales@marknteladvisors.com
